Related Experiment Videos
Pathophysiology of fibrinolysis
I Juhan-Vague1, M C Alessi, P J Declerck
1Laboratoire d'Hématologie, CHU Timone, Marseille, France.
Bailliere'S Clinical Haematology
|June 1, 1995
Summary
Abnormal fibrinolysis, crucial for hemostasis, can lead to bleeding or thrombosis. Deficient fibrinolysis is linked to thrombosis, often due to issues with tissue-type plasminogen activator (t-PA) or its inhibitors.
Area of Science:
- Hematology
- Physiology
- Pathophysiology
Background:
- The fibrinolytic system is vital for hemostasis, regulating blood clot breakdown.
- Abnormalities in fibrinolysis are associated with significant clinical consequences, including bleeding and thrombosis.
Purpose of the Study:
- To elucidate the pathophysiological importance of the fibrinolytic system.
- To detail the mechanisms underlying deficient and excessive fibrinolysis.
Main Methods:
- Review of existing literature on fibrinolysis and hemostasis.
- Analysis of the molecular components involved in fibrinolytic regulation.
Main Results:
- Deficient fibrinolysis, a key factor in thrombosis, can result from impaired tissue-type plasminogen activator (t-PA) synthesis/release or increased t-PA inhibitor levels.
- Excessive fibrinolysis, leading to bleeding, may stem from elevated t-PA, alpha 2-antiplasmin deficiency, or plasminogen activator inhibitor-1 (PAI-1) deficiency.
Conclusions:
- The fibrinolytic system's balance is critical for preventing pathological bleeding and thrombosis.
- Understanding the specific defects in fibrinolysis is essential for managing hemostatic disorders.